saquinavir and Bacterial-Infections

saquinavir has been researched along with Bacterial-Infections* in 1 studies

Other Studies

1 other study(ies) available for saquinavir and Bacterial-Infections

Article	Year
Product information. The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 1998, Volume: 10, Issue:1 The indications, cost, dose, side effects, pharmacokinetics, and drug interactions for soft-gel saquinavir and grepafloxacin are outlined. The bioavailability of soft-gel saquinavir (Fortovase) compared with the hard gel formulation (Invirase) is discussed. Grepafloxacin (Raxar), an oral fluoroquinolone from Glaxo-Wellcome, is active against nearly all strains of S. pneumoniae and will be potentially advantageous for pneumococcal pneumonia in HIV-infected patients. An analysis of Protocol M/333/0021, comparing AZT plus delavirdine (DLV) to AZT plus 3TC and AZT plus 3TC and DLV, is reviewed. A table lists the study results. Topics: Anti-Infective Agents; Bacterial Infections; Biological Availability; Capsules; Clinical Trials as Topic; Delavirdine; Drug Interactions; Drug Therapy, Combination; Drugs, Investigational; Female; Fluoroquinolones; HIV Infections; HIV Protease Inhibitors; Humans; Male; Piperazines; Pregnancy; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir	1998

Article

Year

The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 1998, Volume: 10, Issue:1

The indications, cost, dose, side effects, pharmacokinetics, and drug interactions for soft-gel saquinavir and grepafloxacin are outlined. The bioavailability of soft-gel saquinavir (Fortovase) compared with the hard gel formulation (Invirase) is discussed. Grepafloxacin (Raxar), an oral fluoroquinolone from Glaxo-Wellcome, is active against nearly all strains of S. pneumoniae and will be potentially advantageous for pneumococcal pneumonia in HIV-infected patients. An analysis of Protocol M/333/0021, comparing AZT plus delavirdine (DLV) to AZT plus 3TC and AZT plus 3TC and DLV, is reviewed. A table lists the study results.

Topics: Anti-Infective Agents; Bacterial Infections; Biological Availability; Capsules; Clinical Trials as Topic; Delavirdine; Drug Interactions; Drug Therapy, Combination; Drugs, Investigational; Female; Fluoroquinolones; HIV Infections; HIV Protease Inhibitors; Humans; Male; Piperazines; Pregnancy; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir

1998